Annual Current Liabilities
$2.04 M
+$774.90 K+61.33%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual total current liabilities is currently $2.04 million, with the most recent change of +$774.90 thousand (+61.33%) on 31 December 2023. During the last 3 years, it has risen by +$1.33 million (+188.22%). BLACU annual current liabilities is now at all-time high.BLACU Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$3.94 M
+$523.00 K+15.30%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly total current liabilities is currently $3.94 million, with the most recent change of +$523.00 thousand (+15.30%) on 30 September 2024. Over the past year, it has increased by +$2.84 million (+256.63%). BLACU quarterly current liabilities is now at all-time high.BLACU Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.3% | +256.6% |
| 3 y3 years | +188.2% | +457.3% |
| 5 y5 years | - | - |
BLACU Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +188.2% | at high | +877.0% |
| 5 y | 5 years | at high | +533.8% | at high | +877.0% |
| alltime | all time | at high | +533.8% | at high | +877.0% |
Bellevue Life Sciences Acquisit Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.94 M(+15.3%) |
| June 2024 | - | $3.42 M(+24.5%) |
| Mar 2024 | - | $2.75 M(+34.7%) |
| Dec 2023 | $2.04 M | $2.04 M(+84.4%) |
| Sept 2023 | - | $1.11 M(+104.1%) |
| June 2023 | - | $541.40 K(+34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $403.40 K(-68.1%) |
| Dec 2022 | $1.26 M(+78.6%) | - |
| Dec 2022 | - | $1.26 M(+6.6%) |
| Sept 2022 | - | $1.19 M(+11.6%) |
| June 2022 | - | $1.06 M(+50.2%) |
| Dec 2021 | $707.20 K(+119.9%) | $707.20 K |
| Dec 2020 | $321.60 K | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual total current liabilities?
- What is the all time high annual current liabilities for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual current liabilities year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly current liabilities year-on-year change?
What is Bellevue Life Sciences Acquisit annual total current liabilities?
The current annual current liabilities of BLACU is $2.04 M
What is the all time high annual current liabilities for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual total current liabilities is $2.04 M
What is Bellevue Life Sciences Acquisit annual current liabilities year-on-year change?
Over the past year, BLACU annual total current liabilities has changed by +$774.90 K (+61.33%)
What is Bellevue Life Sciences Acquisit quarterly total current liabilities?
The current quarterly current liabilities of BLACU is $3.94 M
What is the all time high quarterly current liabilities for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly total current liabilities is $3.94 M
What is Bellevue Life Sciences Acquisit quarterly current liabilities year-on-year change?
Over the past year, BLACU quarterly total current liabilities has changed by +$2.84 M (+256.63%)